In glioblastoma patients, SAO are independently associated with younger age, better preoperative clinical performance, certain tumor characteristics (location in the parietal lobe and higher GFAP expression), and serum ion alterations (higher chloride levels). This evidence concerns the gene GFAP and southeast Asian ovalocytosis.